Polymorphism of p53 gene codon 72 in Kuwaiti with coronary artery disease and diabetes

International Journal of Cardiology

Volumn 115, Issue 1, 2007, Pages 1-6

  Alkhalaf, Moussa ^a   Al Bustan, Suzanne ^a   Hamoda, Hesham ^a   Abdella, Nabila ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Coronary artery disease; Diabetes; Kuwait; p53 gene polymorphism

Indexed keywords

ARGININE; CHOLESTEROL; PROLINE; PROTEIN P53; TRIACYLGLYCEROL;

ADULT; ARTICLE; ASIA; CHOLESTEROL BLOOD LEVEL; CODON; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC LINKAGE; GENOTYPE; HUMAN; KUWAIT; MAJOR CLINICAL STUDY; MALE; PILOT STUDY; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; UNITED STATES;

ADULT; AGED; CODON; COMORBIDITY; CORONARY ARTERIOSCLEROSIS; DIABETES MELLITUS; FEMALE; GENE FREQUENCY; GENES, P53; GENOTYPE; HUMANS; KUWAIT; MALE; MIDDLE AGED; PILOT PROJECTS; POLYMORPHISM, GENETIC;

EID: 33845191089     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.01.029     Document Type: Article

References (51)

1. Zhuo Y., Gao J., Luo S., et al. P53 gene codon 72 polymorphism and susceptibility to Keloid in Chinese population. Zhongguo xiu fu Chong Jian Wai Ke Za zhi 19 (2005) 28-30
2. Pietrowski D., Bettendorf H., Riener E.K., et al. Recurrent pregnancy failure is associated with a polymorphism in the p53 tumour suppressor gene. Hum Reprod 20 (2005) 848-851
3. Agorastos T., Masouridou S., Lambropoulos A.F., et al. I. P53 codon 72 polymorphism and correlation with ovarian and endometrial cancer in Greek women. Eur J Cancer Prev 13 (2004) 277-280
4. Brenna S.M., Silva I.D., Zeferino L.C., Pereira J.S., Martinez E.Z., and Syrjanen K.J. Prognostic value of P53 codon 72 polymorphism in invasive cervical cancer in Brazil. Gynecol Oncol 93 (2004) 374-380
5. Ohayon T., Gershoni-Baruch R., Papa M.Z., Distelman Menachem T., Eisenberg Barzilai S., and Friedman E. The R72P P53 mutation is associated with familial breast cancer in Jewish women. Br J Cancer 92 (2005) 1144-1148
6. De Flora S., Izzotti A., Walsh D., Degan P., Petrilli G.L., and Lewtas J. Molecular epidemiology of atherosclerosis. Fed Am Soc Exp Biol J 11 (1997) 1021-1031
7. Markowitz S.D. Atherosclerosis, just another cancer?. J Clin Invest 100 (1997) 2143-2145
8. Andreassi M.G., Botto N., Colombo M.G., Biagini A., and Clerico A. Genetic instability and atherosclerosis: can somatic mutations account for the development of cardiovascular diseases?. Environ Mol Mutagen 35 (2000) 265-269
9. Lane D.P. Cancer. p53, guardian of the genome. Nature 358 (1992) 15-16
10. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
11. Bonafe M., Salvioli S., Barbi C., et al. The different apoptotic potential of the p53 codon 72 alleles increases with age and modulates in vivo ischaemia-induced cell death. Cell Death Differ 11 (2004) 962-973
12. Keim A.L., Chi M.M., and Moley K.H. Hyperglycemia-induced apoptotic cell death in the mouse blastocyst is dependent on expression of p53. Mol Reprod Dev 60 (2001) 214-224
13. Zheng S.J., Lamhamedi-Cherradi S.E., Wang P., Xu L., and Chen Y.H. Tumor suppressor p53 inhibits autoimmune inflammation and macrophage function. Diabetes 54 (2005) 1423-1428
14. Adeghate E. Molecular and cellular basis of the aetiology and management of diabetic cardiomyopathy: a short review. Mol Cell Biochem 261 (2004) 187-191
15. Fiordaliso F., Leri A., Cesselli D., et al. Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death. Diabetes 50 (2001) 2363-2375
16. Zubaid M., Rashed W.A., Husain M., et al. A registry of acute myocardial infarction in Kuwait: patient characteristics and practice patterns. Can J Cardiol 20 (2004) 783-787
17. Shaltout A.A., Moussa M.A., Qabazard M., et al. Kuwait Diabetes Study Group. Further evidence for the rising incidence of childhood type 1 diabetes in Kuwait. Diabet Med 19 (2002) 522-525
18. Abdella N., Al Arouj M., Al Nakhi A., Al Assoussi A., and Moussa M. Non-insulin-dependent diabetes in Kuwait: prevalence rates and associated risk factors. Diabet Res Clin Pract 42 (1998) 187-196
19. Thalib L., Zubaid M., Suresh C.G., Rashed W., and Shukkur M. Diabetes mellitus as a contributor to the in-hospital mortality after acute myocardial infarction in Kuwait. Acta Cardiol 59 (2004) 317-322
20. Zubaid M., Suresh C.G., Thalib L., and Rashed W. Differential distribution of risk factors and outcome of acute coronary syndrome in Kuwait: three years' experience. Med Princ Pract 13 (2004) 63-68
21. Suresh C.G., Zubaid M., Thalib L., Rashed W., and David T. Racial variation in risk factors and occurrence of acute myocardial infarction: comparison between Arab and South Asian men in Kuwait. Indian Heart J 54 (2002) 266-270
22. Kang S., Duan L.H., Zhang J.H., Guo W., Wang N., and Li Y. Association of p53 gene polymorphism with susceptibility to ovarian cancer. Zhonghua Fu Chan Ke Za Zhi 39 (2004) 754-758
23. Vogl F.D., Frey M., Kreienberg R., and Runnebaum I.B. Autoimmunity against p53 predicts invasive cancer with poor survival in patients with an ovarian mass. Br J Cancer 83 (2000) 1338-1343
24. Murata M., Tagawa M., Kimura M., Kimura H., Watanabe S., and Saisho H. Analysis of a germ line polymorphism of the p53 gene in lung cancer patients; discrete results with smoking history. Carcinogenesis 17 (1996) 261-264
25. Wang Y.C., Lee H.S., Chen S.K., Chang Y.Y., and Chen C.Y. Prognostic significance of p53 codon 72 polymorphism in lung carcinomas. Eur J Cancer 35 (1999) 226-230
26. Fan R., Wu M.T., Miller D., et al. The p53 codon 72 polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev 9 (2000) 1037-1042
27. Sjalander A., Birgander R., Hallmans G., et al. p53 polymorphisms and haplotypes in breast cancer. Carcinogenesis 17 (1996) 1313-1316
28. Papadakis E.N., Dokianakis D.N., and Spandidos D.A. p53 codon 72 polymorphism as a risk factor in the development of breast cancer. Mol Cell Biol Res Commun 3 (2000) 389-392
29. Kawaguchi H., Ohno S., Araki K., et al. p53 polymorphism in human papillomavirus-associated esophageal cancer. Cancer Res 60 (2000) 2753-2755
30. Lee J.M., Lee Y.C., Yang S.Y., et al. Genetic polymorphisms of p53 and GSTP1, but not NAT2, are associated with susceptibility to squamous-cell carcinoma of the esophagus. Int J Cancer 89 (2000) 458-464
31. Bastiaens M.T., Struyk L., Tjong-A-Hung S.P., et al. Cutaneous squamous cell carcinoma and p53 codon 72 polymorphism: a need for screening?. Mol Carcinog 30 (2001) 56-61
32. Tandle A.T., Sanghvi V., and Saranath D. Determination of p53 genotypes in oral cancer patients from India. Br J Cancer 84 (2001) 739-742
33. Sun Y., Keshava C., Sharp D.S., Weston A., and McCanlies E.C. DNA sequence variants of p53: cancer and aging. Am J Hum Genet 65 (1999) 1779-1782
34. Speir E., Modali R., Huang E.S., et al. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 265 (1994) 391-394
35. Wang X.L., Wang J., and Wilcken D.E. Interactive effect of the p53 gene and cigarette smoking on coronary artery disease. Cardiovasc Res 35 (1997) 250-255
36. Guevara N.V., Kim H.S., Antonova E.I., and Chan L. The absence of p53 accelerates atherosclerosis by increasing cell proliferation in vivo. Nat Med 5 (1999) 335-339
37. van Vlijmen B.J., Gerritsen G., Franken A.L., et al. Macrophage p53 deficiency leads to enhanced atherosclerosis in APOE*3-Leiden transgenic mice. Circ Res 88 (2001) 780-786
38. Aoki M., Morishita R., Matsushita H., et al. Inhibition of the p53 tumor suppressor gene results in growth of human aortic vascular smooth muscle cells. Potential role of p53 in regulation of vascular smooth muscle cell growth. Hypertension 34 (1999) 192-200
39. Tabas I. p53 and atherosclerosis. Circ Res 88 (2001) 747-749
40. Botto N., Rizza A., Colombo M.G., et al. Evidence for DNA damage in patients with coronary artery disease. Mutat Res 493 (2001) 23-30
41. Benditt E.P., and Benditt J.M. Evidence for a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sci U S A 70 (1973) 1753-1756
42. Bennett M.R. Reactive oxygen species and death: oxidative DNA damage in atherosclerosis. Circ Res 88 (2001) 648-650
43. Lee S.H., and Blair I.A. Oxidative DNA damage and cardiovascular disease. Trends Cardiovasc Med 11 (2001) 148-155
44. Marnett L.J. Oxyradicals and DNA damage. Carcinogenesis 21 (2000) 361-370
45. Sardas S., Yilmaz M., Oztok U., Cakir N., and Karakaya A.E. Assessment of DNA strand breakage by comet assay in diabetic patients and the role of antioxidant supplementation. Mutat Res 490 (2001) 123-129
46. Harangi M., Remenyik E.E., Seres I., Varga Z., Katona E., and Paragh G. Determination of DNA damage induced by oxidative stress in hyperlipidemic patients. Mutat Res 513 (2002) 17-25
47. Al-Muhtaseb N., Al-Yusef A.R., and Bajaj J.S. Lipoprotein lipids and apolipoproteins (AI, AII, B, CII, CIII) in type 1 and type 2 diabetes mellitus in young Kuwaiti women. Diabet Med 8 (1991) 732-737
48. Manfredi S., Masetti S., Botto N., et al. P53 codon 72 polymorphism in coronary artery disease: no evidence for association with increased risk or micronucleus frequency. Environ Mol Mutagen 40 (2002) 110-115
49. Kojima S., Goto Y., Nonogi H., Horie H., Kinoshita M., and Iwai N. Role of a p53 polymorphism in luminal narrowing after balloon coronary angioplasty. Atherosclerosis 151 (2000) 585-586
50. Yonemitsu Y., Kaneda Y., Tanaka S., et al. Transfer of wild-type p53 gene effectively inhibits vascular smooth muscle cell proliferation in vitro and in vivo. Circ Res 82 (1998) 147-156
51. Zee R.Y., Cook N.R., Kim C.A., Fernandez-Cruz A., and Lindpaintner K. TP53 haplotype-based analysis and incidence of post-angioplasty restenosis. Hum Genet 114 (2004) 386-390